Intensity Therapeutics, Inc. Common stock (INTS) Institutional Ownership

Notice: This company has been marked as potentially delisted and may not be actively trading.

Institutional Ownership Changes (13F Filings) for Intensity Therapeutics, Inc. Common stock (NASDAQ:INTS)

Current
Institutional Ownership
Percentage
3.74%
Number of
Institutional Buyers
(last 12 months)
4
Total
Institutional Inflows
(last 12 months)
$8.81M
Number of
Institutional Sellers
(last 12 months)
2
Total
Institutional Outflows
(last 12 months)
$1.33M
Get INTS Insider Trade Alerts

Want to know when executives and insiders are buying or selling Intensity Therapeutics, Inc. Common stock stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

Skip Chart & View Institutional Buying and Selling Data

INTS Institutional Buying and Selling by Quarter

Intensity Therapeutics, Inc. Common stock Major Shareholders & Ownership History

Reporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
4/26/2024 Mesirow Financial Investment Management Inc.44,177$230K0.0%N/A0.322%
4/23/2024 Sapient Capital LLC1,012,069$5.26M0.1%+406.0%7.382%
2/9/2024 Hohimer Wealth Management LLC44,779$384K0.1%-76.0%0.327%
2/6/2024 Sapient Capital LLC200,000$1.71M0.0%N/A1.459%
2/1/2024 Sigma Planning Corp34,443$295K0.0%-28.5%0.251%
1/29/2024 Sapient Capital LLC200,000$1.71M0.1%N/A1.459%
11/21/2023 Hohimer Wealth Management LLC186,464$740K0.2%N/A1.360%
11/6/2023 Sigma Planning Corp48,144$191K0.0%N/A0.352%
(Data available from 1/1/2016 forward)

INTS Institutional Ownership - Frequently Asked Questions

Who are the largest shareholders of INTS shares?

During the previous two years, the following institutional investors and hedge funds held shares of Intensity Therapeutics, Inc. Common stock shares: Sapient Capital LLC ($5.26M), Hohimer Wealth Management LLC ($384K), and Sigma Planning Corp ($295K), Mesirow Financial Investment Management Inc. ($230K).Learn more on INTS's institutional investors.

What percentage of Intensity Therapeutics, Inc. Common stock stock is owned by institutional investors?

3.74% of Intensity Therapeutics, Inc. Common stock stock is owned by institutional investors. Learn more on INTS's institutional investor holdings.

Which institutional investors have been buying Intensity Therapeutics, Inc. Common stock stock?

The following institutional investors have purchased Intensity Therapeutics, Inc. Common stock stock in the last 24 months: Sapient Capital LLC ($1.21M), Hohimer Wealth Management LLC ($186.46K), Sigma Planning Corp ($48.14K), and Mesirow Financial Investment Management Inc. ($44.18K).

How much institutional buying is happening at Intensity Therapeutics, Inc. Common stock?

Institutional investors have bought a total of 1,490,854 shares in the last 24 months. This purchase volume represents approximately $8.81M in transactions.

Which Intensity Therapeutics, Inc. Common stock major shareholders have been selling company stock?

The following institutional investors have sold Intensity Therapeutics, Inc. Common stock stock in the last 24 months: Hohimer Wealth Management LLC ($141.69K), and Sigma Planning Corp ($13.70K).

How much institutional selling is happening at Intensity Therapeutics, Inc. Common stock?

Institutional investors have sold a total of 155,386 shares in the last 24 months. This volume of shares sold represents approximately $1.33M in transactions.


This page (NASDAQ:INTS) was last updated on 5/11/2024 by MarketBeat.com Staff

From Our Partners